Brian Goff Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian Goff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian Goff. Brian Goff is EVP & Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP and President, Hematology in Baxalta Inc ($BXLT).
Brian Goff in ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian Goff: EVP & Chief Commercial Officer
Holdings: 88,696 shares
Current Value: $11,328,253
Latest Transaction: Dec 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Brian Goff in ALEXION PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 157.96 | 3,261 | 515,108 | 67,301 | 70.6 K to 67.3 K (-4.62 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 157.96 | 18,134 | 2,864,447 | 70,562 | 88.7 K to 70.6 K (-20.45 %) |
| Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 40,677 | 0 | 88,696 | 48 K to 88.7 K (+84.71 %) |
| Jun 09 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 114.61 | 1,642 | 188,190 | 48,019 | 49.7 K to 48 K (-3.31 %) |
| Feb 10 2020 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 102.97 | 1,594 | 164,134 | 40,182 | 41.8 K to 40.2 K (-3.82 %) |
| Jun 11 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 118.61 | 1,643 | 194,876 | 41,776 | 43.4 K to 41.8 K (-3.78 %) |
| Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 9,428 | 0 | 43,419 | 34 K to 43.4 K (+27.74 %) |
| Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 132.93 | 670 | 89,063 | 33,991 | 34.7 K to 34 K (-1.93 %) |
| Feb 11 2019 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Payment of Exercise | F | 119.57 | 1,596 | 190,834 | 34,661 | 36.3 K to 34.7 K (-4.40 %) |
| Jun 12 2018 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Sell | S | 118.53 | 1,645 | 194,982 | 36,257 | 37.9 K to 36.3 K (-4.34 %) |
| Mar 02 2018 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 8,940 | 0 | 37,902 | 29 K to 37.9 K (+30.87 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Sell | S | 116.31 | 1,651 | 192,028 | 28,962 | 30.6 K to 29 K (-5.39 %) |
| Feb 08 2018 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 15,894 | 0 | 30,613 | 14.7 K to 30.6 K (+107.98 %) |
| Jun 09 2017 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Option Exercise | A | 100.14 | 21,750 | 2,178,045 | 21,750 | |
| Jun 09 2017 | ALXN | ALEXION PHARMACEUT ... | Goff Brian | EVP & Chief Commerc ... | Grant | A | 0.00 | 14,719 | 0 | 14,719 | 0 to 14.7 K |
Page: 1